Dendritic cell uptake of human apoptotic and necrotic neutrophils inhibits CD40, CD80, and CD86 expression and reduces allogeneic T cell responses: Relevance to systemic vasculitis
Abigail R. Clayton
MRC Centre for Immune Regulation, University of Birmingham Medical School, Birmingham, UK
Search for more papers by this authorRebecca L. Prue
MRC Centre for Immune Regulation, University of Birmingham Medical School, Birmingham, UK
Search for more papers by this authorLorraine Harper
MRC Centre for Immune Regulation, University of Birmingham Medical School, Birmingham, UK
Search for more papers by this authorMark T. Drayson
MRC Centre for Immune Regulation, University of Birmingham Medical School, Birmingham, UK
Search for more papers by this authorCorresponding Author
Caroline O. S. Savage
MRC Centre for Immune Regulation, University of Birmingham Medical School, Birmingham, UK
Renal Immunobiology, MRC Centre for Immune Regulation, Medical School, University of Birmingham, Birmingham B15 2TT, UKSearch for more papers by this authorAbigail R. Clayton
MRC Centre for Immune Regulation, University of Birmingham Medical School, Birmingham, UK
Search for more papers by this authorRebecca L. Prue
MRC Centre for Immune Regulation, University of Birmingham Medical School, Birmingham, UK
Search for more papers by this authorLorraine Harper
MRC Centre for Immune Regulation, University of Birmingham Medical School, Birmingham, UK
Search for more papers by this authorMark T. Drayson
MRC Centre for Immune Regulation, University of Birmingham Medical School, Birmingham, UK
Search for more papers by this authorCorresponding Author
Caroline O. S. Savage
MRC Centre for Immune Regulation, University of Birmingham Medical School, Birmingham, UK
Renal Immunobiology, MRC Centre for Immune Regulation, Medical School, University of Birmingham, Birmingham B15 2TT, UKSearch for more papers by this authorAbstract
Objective
There is a breakdown of tolerance to neutrophil components during systemic vasculitis, which is marked by autoantibodies and T cells with specificity for proteinase 3 or myeloperoxidase, expressed on the surface of apoptotic neutrophils. This study was undertaken to investigate the effects of human apoptotic and necrotic neutrophils on human dendritic cell (DC) phenotype and ability to stimulate allogeneic T cell proliferation.
Methods
DCs were generated from human peripheral blood mononuclear cells and allowed to interact with human apoptotic and necrotic neutrophils in the presence or absence of tumor necrosis factor α (TNFα). Effects on DC phenotype and ability to stimulate T cell proliferation were observed.
Results
Immature DCs engulfed apoptotic and necrotic neutrophils, resulting in up-regulation of CD83 and class II major histocompatibility complex molecules, but down-regulation of CD40, CD80, and CD86, and a decreased ability to stimulate T cell proliferation. When TNFα was added in combination with apoptotic neutrophils, the inhibitory effects were overcome to some extent.
Conclusion
Our results suggest that DC uptake of apoptotic or necrotic neutrophils alone does not shift the immune response from tolerance to autoimmunity in systemic vasculitis. However, cytokines found at sites of inflammation in vasculitis patients may act as maturation factors for DCs, and in combination with apoptotic neutrophils, may lead to an autoimmune phenotype.
REFERENCES
- 1 Steinman RM. The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 1991; 9: 271–96.
- 2 Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998; 392: 245–52.
- 3 Cella M, Salio M, Sakakibara Y, Langen H, Julkunen I, Lanzavecchia A. Maturation, activation, and protection of dendritic cells induced by double-stranded RNA. J Exp Med 1999; 189: 821–9.
- 4 Winzler C, Rovere P, Rescigno M, Granucci F, Penna G, Adorini L, et al. Maturation stages of mouse dendritic cells in growth factor-dependent long-term cultures. J Exp Med 1997; 185: 317–28.
- 5 Luft T, Pang KC, Thomas E, Hetzog P, Hart DNJ, Trapani J, et al. Type I IFNs enhance the terminal differentiation of dendritic cells. J Immunol 1998; 161: 1947–53.
- 6 Green DR, Beere HM. Gone but not forgotten. Nature 2000; 405: 28–9.
- 7 Gallucci S, Lolkema M, Matzinger P. Natural adjuvants: endogenous activators of dendritic cells. Nat Med 1999; 5: 1249–55.
- 8 Steinman RM, Turley S, Mellman I, Inaba K. The induction of tolerance by dendritic cells that have captured apoptotic cells. J Exp Med 2000; 191: 411–6.
- 9 Sauter B, Albert ML, Francisco L, Larsson M, Somersan S, Bhardwaj N. Consequences of cell death: exposure to necrotic tumour cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells. J Exp Med 2000; 191: 423–33.
- 10 Albert ML, Sauter B, Bhardwaj N. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature 1998; 392: 86–9.
- 11 Albert ML, Pearce FA, Francisco LM, Sauter B, Roy P, Silverstein RL, et al. Immature dendritic cells phagocytose apoptotic cells via αvβ5 and CD36, and cross-present antigens to cytotoxic T lymphocytes. J Exp Med 1998; 188: 1359–68.
- 12 Rubartelli A, Poggi A, Zocchi MR. The selective engulfment of apoptotic bodies by dendritic cells is mediated by the αvβ3 integrin and requires intracellular and extracellular calcium. Eur J Immunol 1997; 27: 1893–900.
- 13 Heath WR, Kurts C, Miller JFAP, Carbone FR. Cross-tolerance: a pathway for inducing tolerance to peripheral tissue antigens. J Exp Med 1998; 187: 1549–53.
- 14 Salio M, Cerundolo V, Lanzavecchia A. Dendritic cell maturation is induced by mycoplasma infection but not by necrotic cells. Eur J Immunol 2000; 30: 705–8.
- 15 Rovere P, Vallinoto C, Bondanza A, Crosti MC, Rescigno M, Ricciardi-Castagnoli P, et al. Cutting edge: bystander apoptosis triggers dendritic cell maturation and antigen-presenting function. J Immunol 1998; 161: 4467–71.
- 16 Rovere P, Sabbadini MG, Vallinoto C, Fascio U, Rescigno M, Crosti M, et al. Dendritic cell presentation of antigens from apoptotic cells in a proinflammatory context: role of opsonizing anti–β2-glycoprotein I antibodies. Arthritis Rheum 1999; 42: 1412–20.
- 17 Rovere P, Manfredi AA, Vallinoto C, Zimmermann VS, Fascio U, Balestrieri G, et al. Dendritic cells preferentially internalize apoptotic cells opsonized by anti-β2-glycoprotein I antibodies. J Autoimmun 1998; 11: 403–11.
- 18
Van der Woude FJ,
Rasmussen N,
Lobatto S,
Wiik A,
Permin H,
van Es LA, et al.
Autoantibodies against neutrophils and monocytes: tools for diagnosis and marker of disease activity in Wegener's granulomatosis.
Lancet
1985;
ii:
425–9.
10.1016/S0140-6736(85)91147-X Google Scholar
- 19 Falk RJ, Jennette JC. Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N Engl J Med 1988; 318: 1651–7.
- 20
Savage COS,
Winearls CG,
Jones S,
Marshall PD,
Lockwood CM.
Prospective study of radioimmunoassay for antibodies against neutrophil cytoplasm in diagnosis of systemic vasculitis.
Lancet
1987;
i:
1389–93.
10.1016/S0140-6736(87)90591-5 Google Scholar
- 21 Gaskin G, Savage COS, Ryan JJ, Jones S, Rees AJ, Lockwood CM, et al. Anti-neutrophil cytoplasmic antibodies and disease activity during long-term follow-up of 70 patients with systemic vasculitis. Nephrol Dial Transplant 1991; 6: 689–94.
- 22 Kallenberg CGM, Brouwer E, Weening JJ, Cohen Tervaert JW. Anti-neutrophil cytoplasmic antibodies: current diagnostic and pathophysiological potential. Kidney Int 1994; 46: 1–15.
- 23
Harper L,
Savage COS.
Pathogenesis of ANCA-associated systemic vasculitis.
J Pathol
2000;
190:
349–59.
10.1002/(SICI)1096-9896(200002)190:3<349::AID-PATH524>3.0.CO;2-A CAS PubMed Web of Science® Google Scholar
- 24 Csernok E, Ernst M, Schmitt W, Bainton DF, Gross WL. Activated neutrophils express proteinase 3 on their plasma membrane in vitro and in vivo. Clin Exp Immunol 1994; 95: 244–50.
- 25 Charles LA, Caldas MLR, Falk RJ, Terrell RS, Jennette JC. Antibodies against granule proteins activate neutrophils in vitro. J Leukoc Biol 1991; 50: 539–46.
- 26 Gilligan HM, Bredy B, Brady HR, Hébert M-J, Slayter HS, Xu Y, et al. Antineutrophil cytoplasmic autoantibodies interact with primary granule constituents on the surface of apoptotic neutrophils in the absence of neutrophil priming. J Exp Med 1996; 184: 2231–41.
- 27 Falk RJ, Terrel RS, Charles LA, Jennette JC. Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Proc Natl Acad Sci U S A 1990; 87: 4115–9.
- 28 Savage COS, Pottinger BE, Gaskin G, Pusey CD, Pearson JD. Autoantibodies developing to myeloperoxidase and proteinase 3 in systemic vasculitis stimulate neutrophil cytotoxicity toward cultured endothelial cells. Am J Pathol 1992; 141: 335–42.
- 29 Ewert BH, Jennette JC, Falk RJ. Anti-myeloperoxidase antibodies stimulate neutrophils to damage human endothelial cells. Kidney Int 1992; 41: 375–83.
- 30 Harper L, Ren Y, Savill J, Adu D, Savage COS. Antineutrophil cytoplasmic antibodies induce reactive oxygen-dependent dysregulation of primed neutrophil apoptosis and clearance by macrophages. Am J Pathol 2000; 157: 211–20.
- 31 Devaney KO, Travis WD, Hoffmann G, Leavitt R, Lebovics R, Fauci AS. Interpretation of head and neck biopsies in Wegener's granulomatosis. Am J Surg Pathol 1990; 14: 555–64.
- 32 Del Buono EA, Flint A. Diagnostic usefulness of nasal biopsy in Wegener's granulomatosis. Hum Pathol 1991; 22: 107–10.
- 33 Matsubara O, Yoshimura N, Doi Y, Tamura A, Mark EJ. Nasal biopsy in the early diagnosis of Wegener's (pathergic) granulomatosis. Virchows Arch 1996; 428: 13–9.
- 34 Harper L, Cockwell P, Adu D, Savage COS. Neutrophil priming and apoptosis in anti-neutrophil cytoplasmic autoantibody-associated vasculitis. Kidney Int 2001; 59: 1729–38.
- 35 Patry YC, Trewick DC, Gregoire M, Audrain MAP, Moreau AMN, Muller J-Y, et al. Rats injected with syngenic rat apoptotic neutrophils develop antineutrophil cytoplasmic antibodies. J Am Soc Nephrol 2001; 12: 1764–8.
- 36 Vanderheyde N, Verhasselt V, Goldman M, Willems F. Inhibition of human dendritic cell functions by methylprednisolone. Transplantation 1999; 67: 1342–7.
- 37 Brooks CJ, King WJ, Radford DJ, Adu D, McGrath M, Savage COS. IL-1β production by human polymorphonuclear leucocytes stimulated by anti-neutrophil cytoplasmic autoantibodies: relevance to systemic vasculitis. Clin Exp Immunol 1996; 106: 273–9.
- 38 Savill JS, Wyllie AH, Henson JE, Walport MJ, Henson PM, Haslett C. Macrophage phagocytosis of aging neutrophils in inflammation: programmed cell death in the neutrophil leads to its recognition by macrophages. J Clin Invest 1989; 83: 865–75.
- 39 Newman SL, Henson JE, Henson PM. Phagocytosis of senescent neutrophils by human monocyte-derived macrophages and rabbit inflammatory macrophages. J Exp Med 1982; 156: 430–42.
- 40 Allsopp CEM, Nicholls SJ, Langhorne J. A flow cytometric method to assess antigen-specific proliferative responses of different subpopulations of fresh and cryopreserved human peripheral blood mononuclear cells. J Immunol Methods 1998; 214: 175–86.
- 41 Givan AL, Fisher JL, Waugh M, Ernstoff MS, Wallace PK. A flow cytometric method to estimate the precursor frequencies of cells proliferating in response to specific antigens. J Immunol Methods 1999; 230: 99–112.
- 42 Freudenthal PS, Steinman RM. The distinct surface of human blood dendritic cells, as observed after an improved isolation method. Proc Natl Acad Sci U S A 1990; 87: 7698–702.
- 43 Urban BC, Willcox N, Roberts DJ. A role for CD36 in the regulation of dendritic cell function. Proc Natl Acad Sci U S A 2001; 98: 8750–5.
- 44 Stuart LM, Lucas M, Simpson C, Lamb J, Savill J, Lacy-Hulbert A. Inhibitory effects of apoptotic cell ingestion upon endotoxin-driven myeloid dendritic cell maturation. J Immunol 2002; 168: 1627–35.
- 45 Voll RE, Herrmann M, Roth EA, Stach C, Kalden JR. Immunosuppressive effects of apoptotic cells. Nature 1997; 390: 350–1.
- 46 Fadok VA, Bratton DL, Konowal A, Freed PW, Westcott JY, Henson PM. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-β, PGE2, and PAF. J Clin Invest 1998; 101: 890–8.
- 47 Ren Y, Stuart L, Lindberg FP, Rosenkranz AR, Chen Y, Mayadas TN, et al. Nonphlogistic clearance of late apoptotic neutrophils by macrophages: efficient phagocytosis independent of β2 integrins. J Immunol 2001; 166: 4743–50.
- 48 Fadok VA, Bratton DL, Guthrie L, Henson PM. Differential effects of apoptotic versus lysed cells on macrophage production of cytokines: role of proteases. J Immunol 2001; 166: 6847–54.
- 49 Barker RN, Erwig L-P, Hill KSK, Devine A, Pearce WP, Rees AJ. Antigen presentation by macrophages is enhanced by the uptake of necrotic, but not apoptotic, cells. Clin Exp Immunol 2002; 127: 220–5.
- 50 Deguchi Y, Shibata N, Kishimoto S. Enhanced expression of the tumour necrosis factor/cachectin gene in peripheral blood mononuclear cells from patients with systemic vasculitis. Clin Exp Immunol 1990; 81: 311–4.
- 51 Noronha IL, Krüger C, Andrassy K, Ritz E, Waldherr R. In situ production of TNF-α, IL-1β and IL-2R in ANCA-positive glomerulonephritis. Kidney Int 1993; 43: 682–92.
- 52 Lúdvíksson BR, Sneller MC, Chua KS, Talar-Williams C, Langford CA, Ehrhardt RO, et al. Active Wegener's granulomatosis is associated with HLA-DR+ CD4+ T cells exhibiting an unbalanced Th1-type T cell cytokine pattern: reversal with IL-10. J Immunol 1998; 160: 3602–9.
- 53 Moosig F, Csernok E, Kumanovics G, Gross WL. Opsonization of apoptotic neutrophil cytoplasmic antibodies (ANCA) leads to enhanced uptake by macrophages and increased release of tumour necrosis factor-alpha (TNF-α). Clin Exp Immunol 2000; 122: 499–503.
- 54 Pinching AJ, Lockwood CM, Pussell BA, Rees AJ, Sweny P, Evans DJ, et al. Wegener's granulomatosis: observations on 18 patients with severe renal disease. QJM 1983; 208: 435–60.
- 55 Pinching AJ, Rees AJ, Pussell BA, Lockwood CM, Mitchison RS, Peters DK. Relapses in Wegener's granulomatosis: the role of infection. BMJ 1980; 281: 836–8.